阿维 A 酯治疗难治性多激酶抑制剂诱导的手足皮肤反应的疗效。
Outcomes of Acitretin Treatment for Refractory Multikinase Inhibitor-Induced Hand-Foot Skin Reaction.
机构信息
Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
Harvard Medical School, Boston, Massachusetts.
出版信息
JAMA Dermatol. 2022 Jul 1;158(7):824-826. doi: 10.1001/jamadermatol.2022.1425.
Abstract
This cohort study assesses the outcomes of acitretin treatment for multikinase inhibitor–associated hand-foot skin reaction.
摘要
这项队列研究评估了阿维 A 治疗多激酶抑制剂相关手足皮肤反应的疗效。
相似文献
1
Outcomes of Acitretin Treatment for Refractory Multikinase Inhibitor-Induced Hand-Foot Skin Reaction.阿维 A 酯治疗难治性多激酶抑制剂诱导的手足皮肤反应的疗效。
JAMA Dermatol. 2022 Jul 1;158(7):824-826. doi: 10.1001/jamadermatol.2022.1425.
2
Hand-foot-skin reaction related to use of the multikinase inhibitor sorafenib and hard orthotics.与使用多激酶抑制剂索拉非尼及硬支具相关的手足皮肤反应
Pediatr Dermatol. 2018 Jul;35(4):e206-e209. doi: 10.1111/pde.13523. Epub 2018 May 15.
3
Sorafenib-associated hand-foot skin reaction: practical advice on diagnosis, mechanism, prevention, and management.索拉非尼相关手足皮肤反应：诊断、机制、预防和管理的实用建议。
Expert Rev Clin Pharmacol. 2019 Dec;12(12):1121-1127. doi: 10.1080/17512433.2019.1689122. Epub 2019 Nov 8.
4
Hand-foot skin reaction induced by sorafenib in a hepatocellular carcinoma patient.索拉非尼诱发的一名肝细胞癌患者的手足皮肤反应
Postgrad Med J. 2020 Aug;96(1138):495. doi: 10.1136/postgradmedj-2019-137059. Epub 2019 Sep 24.
5
Regorafenib-associated hand-foot skin reaction: practical advice on diagnosis, prevention, and management.瑞戈非尼相关的手足皮肤反应：关于诊断、预防及管理的实用建议
Ann Oncol. 2015 Oct;26(10):2017-26. doi: 10.1093/annonc/mdv244. Epub 2015 Jun 1.
6
Clinical presentation and management of hand-foot skin reaction associated with sorafenib in combination with cytotoxic chemotherapy: experience in breast cancer.索拉非尼联合细胞毒性化疗治疗相关手足皮肤反应的临床特征和处理：乳腺癌的经验。
Oncologist. 2011;16(11):1508-19. doi: 10.1634/theoncologist.2011-0115. Epub 2011 Oct 20.
7
Hand-foot skin reaction is associated with the clinical outcome in patients with metastatic renal cell carcinoma treated with sorafenib.手足皮肤反应与索拉非尼治疗转移性肾细胞癌患者的临床结局相关。
Jpn J Clin Oncol. 2013 Oct;43(10):1023-9. doi: 10.1093/jjco/hyt110. Epub 2013 Aug 15.
8
Sorafenib-induced hand-foot syndrome in a patient of renal cell carcinoma.索拉非尼诱发的肾细胞癌患者手足综合征。
Indian J Pharmacol. 2014 May-Jun;46(3):334-6. doi: 10.4103/0253-7613.132189.
9
Perianal erosion in a patient with sorafenib-induced hand-foot syndrome: A case report.索拉非尼诱导的手足综合征患者的肛周糜烂：一例报告。
J Dermatol. 2023 Oct;50(10):e344-e346. doi: 10.1111/1346-8138.16853. Epub 2023 Jun 7.
10
Lipid profiling of pre-treatment plasma reveals biomarker candidates associated with response rates and hand-foot skin reactions in sorafenib-treated patients.治疗前血浆脂质组学分析揭示索拉非尼治疗患者的反应率和手足皮肤反应相关的生物标志物候选物。
Cancer Chemother Pharmacol. 2018 Oct;82(4):677-684. doi: 10.1007/s00280-018-3655-z. Epub 2018 Jul 30.
本文引用的文献
1
Association of Hand-Foot Skin Reaction with Regorafenib Efficacy in the Treatment of Metastatic Colorectal Cancer.手足皮肤反应与regorafenib 治疗转移性结直肠癌疗效的相关性。
Oncology. 2019;96(4):200-206. doi: 10.1159/000495989. Epub 2019 Feb 14.
2
Regorafenib-associated hand-foot skin reaction: practical advice on diagnosis, prevention, and management.瑞戈非尼相关的手足皮肤反应：关于诊断、预防及管理的实用建议
Ann Oncol. 2015 Oct;26(10):2017-26. doi: 10.1093/annonc/mdv244. Epub 2015 Jun 1.
3
Risk of hand-foot skin reaction with the novel multikinase inhibitor regorafenib: a meta-analysis.新型多激酶抑制剂regorafenib 所致手足皮肤不良反应风险：一项荟萃分析。
Invest New Drugs. 2013 Aug;31(4):1078-86. doi: 10.1007/s10637-013-9977-0. Epub 2013 May 23.
4
An updated review of acitretin--a systemic retinoid for the treatment of psoriasis.阿维A——一种用于治疗银屑病的系统性类维生素A药物的最新综述。
Expert Opin Drug Metab Toxicol. 2008 Jul;4(7):953-64. doi: 10.1517/17425255.4.7.953.
5
Hand-foot skin reaction in patients treated with sorafenib: a clinicopathological study of cutaneous manifestations due to multitargeted kinase inhibitor therapy.索拉非尼治疗患者的手足皮肤反应：多靶点激酶抑制剂治疗所致皮肤表现的临床病理研究
Br J Dermatol. 2008 Mar;158(3):592-6. doi: 10.1111/j.1365-2133.2007.08357.x. Epub 2007 Dec 6.
6
Acitretin in the treatment of severe disorders of keratinization. Results of an open study.阿维A治疗严重角化异常疾病。一项开放性研究的结果。
J Am Acad Dermatol. 1991 Jun;24(6 Pt 1):982-6. doi: 10.1016/0190-9622(91)70158-x.
Zotero 插件